The current price is only for small quantities and the first harvest of the season, says DP Maheshwari, MD and CEO of Jayshree Tea. A chief worry for industry is the rising production costs of Darjeeling tea, says K Datta, CMD of Andrew Yule.
Andrew Yule & Co has ceased to be a sick industrial unit and the stock is spiking up nicely. In fact in the past 12 months itself the stock has gained around 30 percent odd.